ID
12935
Beschrijving
Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00005908
Link
https://clinicaltrials.gov/show/NCT00005908
Trefwoorden
Versies (1)
- 06-01-16 06-01-16 -
Geüploaded op
6 januari 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00005908
Eligibility Breast Cancer NCT00005908
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
comorbidity
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009488
Beschrijving
pregnancy, lactating
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C2828358
Beschrijving
bleeding disorders
Datatype
boolean
Alias
- UMLS CUI [1]
- C0005779
Beschrijving
hypersensitivity
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0041417
Beschrijving
heart disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0018799
Beschrijving
chemotherapy, hormone therapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C0279025
Beschrijving
malignancy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0006826
Similar models
Eligibility Breast Cancer NCT00005908
- StudyEvent: Eligibility
C0027646 (UMLS CUI [1,2])
C0005558 (UMLS CUI [2])
C0032181 (UMLS CUI [2])
C0201836 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0201850 (UMLS CUI [4])
C0449820 (UMLS CUI [1,2])
C2828358 (UMLS CUI [2])
C0041417 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2])